Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study

Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study

Abstract. Invasive fungal diseases (IFDs) remain a major clinical issue in patients with hematological malignancies (HMs). To confirm the efficacy and safety of the new azole isavuconazole (ISV) in a clinical care setting, we planned a multicenter retrospective study; we collected data on all possib...

Full description

Bibliographic Details
Main Authors:	Chiara Cattaneo, Alessandro Busca, Doriana Gramegna, Francesca Farina, Anna Candoni, Monica Piedimonte, Nicola Fracchiolla, Chiara Pagani, Maria Ilaria Del Principe, Maria Chiara Tisi, Massimo Offidani, Rosa Fanci, Stelvio Ballanti, Angelica Spolzino, Marianna Criscuolo, Francesco Marchesi, Gianpaolo Nadali, Mario Delia, Marco Picardi, Margherita Sciumé, Valentina Mancini, Attilio Olivieri, Mario Tumbarello, Giuseppe Rossi, Livio Pagano
Format:	Article
Language:	English
Published:	Wiley 2019-12-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000320

Similar Items

High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study
by: Chiara Cattaneo, et al.
Published: (2022-05-01)

P487: MIDOSTAURIN PLASMA EXPOSURE IN PATIENTS WITH FLT3-MUT ACUTE MYELOID LEUKEMIA UNDERGOING POSACONAZOLE PROPHYLAXIS DURING INDUCTION TREATMENT: A PROSPECTIVE MULTICENTRE STUDY FROM THE SEIFEM GROUP
by: Francesco Marchesi, et al.
Published: (2023-08-01)

Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in “Real-Life”: The SEIFEM Experience
by: Luana Fianchi, et al.
Published: (2023-07-01)

Correction Notice – Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study
Published: (2023-11-01)

Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
by: Enrico Maria Trecarichi, et al.
Published: (2019-01-01)

Isavuconazole for COVID-19-Associated Invasive Mold Infections
by: Nadir Ullah, et al.
Published: (2022-06-01)

Isavuconazole—Animal Data and Clinical Data
by: Livio Pagano, et al.
Published: (2020-10-01)

When Viruses Meet Fungi: Tackling the Enemies in Hematology
by: Alessandro Busca, et al.
Published: (2022-02-01)

P1509: CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND PREVIOUS INFECTIONS HAD IMPACT ON INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH VENETOCLAX: A MULTICENTRE SEIFEM STUDY
by: Francesco Autore, et al.
Published: (2023-08-01)

Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study
by: Pierantonio Menna, et al.
Published: (2023-10-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
by: Hirsh Elhence, et al.
Published: (2022-12-01)

Isavuconazole as salvage therapy for mucormycosis
by: Bianca Graves, et al.
Published: (2016-03-01)

Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against <i>Aspergillus fumigatus</i> and <i>Aspergillus flavus</i> in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?
by: Pier Giorgio Cojutti, et al.
Published: (2021-12-01)

Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
by: Marta Ilharco, et al.
Published: (2019-01-01)

Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.
by: Salvatore Perrone, et al.
Published: (2020-04-01)

Clinical pharmacology and practical aspects of isavuconazole use
by: Veselov A.V.
Published: (2023-12-01)

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
by: Misti Ellsworth, et al.
Published: (2020-11-01)

Upper extremity Histoplasma capsulatum treatment with isavuconazole
by: Janet Le, et al.
Published: (2021-01-01)

Role of isavuconazole in the treatment of invasive fungal infections
by: Wilson DT, et al.
Published: (2016-08-01)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
by: Donnelley MA, et al.
Published: (2016-06-01)

Late-onset isavuconazole-induced liver injury
by: Felix Bongomin, et al.
Published: (2018-12-01)

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations
by: Christoph Zurl, et al.
Published: (2020-06-01)

Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.
by: Mario Tumbarello, et al.
Published: (2012-01-01)

Population Pharmacokinetics of Isavuconazole in Adult: A Systematic Review
by: Chen N, et al.
Published: (2023-12-01)

Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients
by: Philippe Zimmermann, et al.
Published: (2022-03-01)

Penetration of Isavuconazole in Ascites Fluid of Critically Ill Patients
by: Tobias Lahmer, et al.
Published: (2021-05-01)

In Vitro Activity of Isavuconazole and Amphotericin B in Association against Mucorales
by: Gaia Ortalli, et al.
Published: (2023-07-01)

Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo
by: Ya-nan Liu, et al.
Published: (2023-05-01)

Clinical research advances of isavuconazole in the treatment of invasive fungal diseases
by: Tingting Zhang, et al.
Published: (2022-12-01)

Pharmacokinetics of isavuconazole in healthy cats after oral and intravenous administration
by: Dennis J. Woerde, et al.
Published: (2022-07-01)

Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
by: Jonathan Huggins, et al.
Published: (2019-03-01)

In vitro synergy of isavuconazole in combination with colistin against Candida auris
by: Patrick Schwarz, et al.
Published: (2020-12-01)

Isavuconazole Breakthrough Disseminated *Fusarium fujikuroi* Infection in a Patient with Allogeneic Hematopoietic Stem Cell Transplant: Diagnostic and Therapeutic Challenges – A Case Report
by: Davide Bosetti, et al.
Published: (2023-03-01)

Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients
by: Jose Tiago Silva, et al.
Published: (2023-12-01)

Experience of Isavuconazole as a Salvage Therapy in Chronic Pulmonary Fungal Disease
by: Lisa Nwankwo, et al.
Published: (2022-03-01)

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
by: Léa Bolcato, et al.
Published: (2022-09-01)

Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association
by: Andrea Duminuco, et al.
Published: (2021-11-01)

In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
by: Patrick Schwarz, et al.
Published: (2022-04-01)

Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections
by: Falci DR, et al.
Published: (2013-10-01)

HIV-associated disseminated histoplasmosis successfully treated with isavuconazole consolidation therapy
by: Andrea Mazzella, et al.
Published: (2020-03-01)